The presence of a specific scleroderma subtype and autoantibodies may be reliable factors to identify a distinct cancer risk in patients with scleroderma, according to a large prospective study. The study, “Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer,” was published in…
News
Treatment with iloprost using a portable pump is efficient, safe, and more convenient for the treatment of Raynaud’s phenomenon and digital ulcers in patients with scleroderma, a case report from Portugal shows. The pump helps patients…
The occurrence of blood clots in the veins of scleroderma patients is rare and does not change patients’ survival rates, a new Canadian study shows. Still, researchers see a need for improved understanding of venous thromboembolism (VTE) in these patients. The study, “Venous Thromboembolism in Systemic Sclerosis: Prevalence,…
News
Interstitial Lung Disease Associated with Greater Risk of Lung Cancer in Scleroderma, Study Reports
Having interstitial lung disease (ILD) is associated with a greater risk of lung cancer in scleroderma patients, according to Canadian researchers. Their findings also demonstrate that male sex and smoking are predictors for increased risk. Their study, “Interstitial lung disease is associated with an increased risk of lung…
A little-known government entity within the National Institutes of Health (NIH) is helping to lead U.S. efforts to speed up the development of therapies for some 7,000 rare diseases. The Office of Rare Diseases Research (ORDR), headquartered in Bethesda, Maryland, was established in 1993 within the NIH Office of the…
Therapeutic plasma exchange, which aims to treat systemic sclerosis (SSc) by clearing the blood of antibodies, cytokines and other factors that might promote disease progression, shows potential as a therapy, a review study reported. But a well-designed clinical trial, incorporating equipment and techniques that have come into use since therapeutic…
Increased levels of two proteins produced during acute inflammation can help predict pulmonary involvement in patients with diffuse systemic sclerosis, a study shows. Patients with diffuse systemic sclerosis who also have developed lung disease were found to have significantly higher levels of C-reactive protein (CRP) and serum amyloid A…
Changes in gene expression occur early in scleroderma patients with pulmonary arterial hypertension or interstitial lung disease, which means that a collection of biomarkers can be used to detect these lung conditions early, a study reports. The research dealt with what scientists call a biomarker panel for the conditions. The…
Almost a quarter of systemic sclerosis (SSc) patients with reduced gas exchange develop pulmonary hypertension (PH) within three years, according to a recent study that used right heart catheterization to measure pulmonary arterial pressures. Regular tests to assess PH, including right heart catheterization (RHC), might be useful in…
Severe malnutrition significantly decreases the quality of life of patients with systemic sclerosis (SSc), according to researchers. Standardized nutritional screening is needed to identify those at risk of malnutrition so that interventions are rapidly introduced to avoid disease worsening. The study, “The impact of malnutrition on…
Recent Posts
- Anti-CD146 antibodies may signal occupational exposure in SSc: Study
- New SSc drug safely cuts Raynaud’s attack duration, eases symptoms
- Carbon dioxide hand baths may help in SSc-related Raynaud’s, study finds
- More SSc-ILD patients receive early treatment, new study finds
- CD13 levels elevated in scleroderma, but biomarker value unclear
- New lab findings support development of stem cell treatments for SSc-ILD
- Type of immune cell may be key driver of scleroderma scarring: Study
- Abnormal fatty acid metabolism may play role in scleroderma: Analysis
- Cosmetic laser therapy could be repurposed for localized scleroderma
- Antibody levels may help reflect quality of life in people with scleroderma